Researchers have found, in mice with pulmonary fibrosis and with dominant immune response mediated by immune Th2 cells (T-helper cells), that aerobic exercise reduced lung fibrosis. The study, “Aerobic Exercise Attenuated Bleomycin-Induced Lung Fibrosis in Th2-Dominant Mice,” was published in the journal PLOS One. Fibrosis is the scarring and thickening…
Aerobic Exercise Reduces Lung Fibrosis in Mice, Study Shows
Idiopathic pulmonary fibrosis (IPF) is a rare and chronic lung disease that causes scarring of the lung tissue which leads to difficulties in breathing and a persistent dry cough. Because it only affects only up to 43 people in every 100,000, it is designated as an “orphan disease.” Read…
Recent research suggested that the hormone leptin is a potentially promising plasma biomarker of acute exacerbation (AE) and predictor of survival in patients with idiopathic pulmonary fibrosis (IPF). This is the first report associating leptin levels with IPF or AE-IPF, and could hold great potential to improve disease monitoring. The study…
Pulmonary fibrosis is a lung disease that causes scarring in the tissue of the lungs. It leads to shortness of breath, a persistent dry cough, weight loss, fatigue, and clubbing of the fingers and toes. Read about how you can teach your lungs to improve your breathing. In this…
If you’ve recently been diagnosed with pulmonary fibrosis, there are probably loads of questions running through your mind. Here are some of the most important questions you should ask your doctor according to the American Lung Association. 1. “What is pulmonary fibrosis?” Pulmonary fibrosis (PF) literally means scarring of the lungs.
Patients with idiopathic pulmonary fibrosis (IPF) who demonstrate adequate lung volume still have the same rate of lung volume decline as patients with initially lower volumes, and benefit equally from treatment with Ofev (nintedanib), researchers reported. The study, “Nintedanib in patients with idiopathic pulmonary fibrosis and preserved…
Idiopathic Pulmonary fibrosis (IPF) is a difficult disease to diagnose because many of its symptoms are similar to other lung diseases. There is no one single test for the condition. Instead, a series of tests are carried out to diagnose the condition. One test is auscultation.
Allakos recently presented preclinical data demonstrating the potential of its Siglec-8 antibodies in inhibiting components involved in fibrosis in rodent models of lung and skin fibrosis. The company believes these antibodies could potentially benefit a wide spectrum of patients with conditions where fibrosis is a major contributor to the…
What is Aromatherapy? Have you heard about essential oils? They aren’t anything new. “Essential oil” is basically a different name for an old standby, aromatherapy. There’s plenty of research behind this aromatic trend that shows it can help to alleviate many health conditions. We’ve uncovered some ways essential oils can help you deal…
In this PeerView Press video, pulmonologist Dr. David J. Lederer discusses idiopathic pulmonary fibrosis (IPF), with a focus on personalized care through communications and innovative strategies. He is joined by primary care physician Dr. Steven J. Antonini and pulmonary fibrosis patient Robert Brynteson. Read about six lesser-known symptoms…
